Preclinical prevent cancer program: preclinical efficacy and intermediate endpoint biomarkerspop:9/22/2015 - 9/21/2018

Ended Awarded Last action

Contract number
HHSN261201500038I
Awardee
Awarding agency
Task orders
8 $4,115,356 obligated

Award facts

Combined order value
$4,115,356 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 14% used
$29,800,000.00
Maximum order
$19,800,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Prevent efficacy task order: chemoprevention of colorectal cancer with olmesartan medoxomil HHSN26100011 National Cancer Institute (NIH) $521,215
Prevention of endometrial hyperplasia and its transition to endometrial cancer with SHETA2 POP 6/1/2017 - 5/31/2019 HHSN26100008 National Cancer Institute (NIH) $709,326
Prevention of colorectal cancer by ONC201 9/16 - 9/18 HHSN26100006 National Cancer Institute (NIH) $221,345
Prostate cancer prevention by aspirin and/or other nsaids torfp 2016-E03HHSN2612015000381PERIOD of performance… HHSN26100005 National Cancer Institute (NIH) $834,263
Combination of aspirin or naproxen with omerprazole for colorectal cancer chemoprevention with clinically relevant doses HHSN26100003 National Cancer Institute (NIH) $598,079
R & D- medical: biomedical (basic research) HHSN26100002 National Cancer Institute (NIH) $628,343
Prevent efficacy: optimization of GEM models for high-risk cohorts of human pancreatic cystadenomas, ipmns, and… HHSN26100004 National Cancer Institute (NIH) $598,567
Contract orientation and kick-off meeting period of performance: 09/22/2015 - 12/31/2015 HHSN26100001 National Cancer Institute (NIH) $4,217

Transactions

Action Obligated Date
Additional Work (new agreement, FAR part 6 applies) 2 $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201500038I?

HHSN261201500038I was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500038I worth?

Orders under HHSN261201500038I have obligated $4,115,356. HHSN261201500038I's own ceiling is $29,800,000. A single order can be worth up to $19,800,000.

How many orders have been placed under contract HHSN261201500038I?

8 orders have been placed under HHSN261201500038I, the latest on September 15, 2017.

Who can order from contract HHSN261201500038I?

HHSN261201500038I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201500038I part of a contract vehicle?

Yes. HHSN261201500038I is part of PREVENT Cancer Program (PREVENT).

Was contract HHSN261201500038I competed?

The extent of competition for HHSN261201500038I was full and open competition. The government received 9 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login